James Renwick Mccullough - Net Worth and Insider Trading

James Renwick Mccullough Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, James Renwick Mccullough owns 1 companies in total, including Renalytix PLC (RNLX) .

Click here to see the complete history of James Renwick Mccullough’s form 4 insider trades.

Insider Ownership Summary of James Renwick Mccullough

Ticker Comapny Transaction Date Type of Owner
RNLX Renalytix PLC 2023-07-01 director & Chief Executive Officer

James Renwick Mccullough Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

James Renwick Mccullough Ownership Network

Ownership Network List of James Renwick Mccullough

No Data

Ownership Network Relation of James Renwick Mccullough


James Renwick Mccullough Owned Company Details

What does Renalytix PLC do?

Who are the key executives at Renalytix PLC?

James Renwick Mccullough is the director & Chief Executive Officer of Renalytix PLC. Other key executives at Renalytix PLC include Chief Business Officer Howard Jr Doran , President Thomas H Mclain , and 10 percent owner Mount Sinai Health System, Inc. .

Renalytix PLC (RNLX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Renalytix PLC (RNLX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Renalytix PLC (RNLX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Renalytix PLC (RNLX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Renalytix PLC Insider Transactions

No Available Data

James Renwick Mccullough Mailing Address

Above is the net worth, insider trading, and ownership report for James Renwick Mccullough. You might contact James Renwick Mccullough via mailing address: C/o Renalytix Plc, Finsgate, 5-7 Cranwood Street, London X0 Ec1v 9ee.

Discussions on James Renwick Mccullough

No discussions yet.